We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alembic Pharmaceuticals Draws Form 483 Over Five Quality Observations
Alembic Pharmaceuticals Draws Form 483 Over Five Quality Observations
Alembic Pharmaceuticals, a sterile drug manufacturer in Gujarat, India, drew a Form 483 inspection report from the FDA with five observations following a Jan. 28 – Feb. 6 inspection.